Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-01-18

Clinical Trial Update: GAMBIT Trial: Cisplatin Plus Irinotecan in the Treatment of Gallbladder or Biliary Tract Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cisplatin plus irinotecan for biliary cancer (gallbladder or biliary tract cancer). Status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • cisplatin + irinotecan

Snippet

Sponsor: Hospital de Cancer de Barretos - Fundacao Pio XII | Conditions: Biliary Cancer | Phase 2 | Status: UNKNOWN